Authors:
Skomedal, H
Kristensen, GB
Nesland, JM
Borresen-Dale, AL
Trope, C
Holm, R
Citation: H. Skomedal et al., TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, cdk4, RB, MDM2, and EGFR in cancers of the uterine corpus, J PATHOLOGY, 187(5), 1999, pp. 556-562
Authors:
Kristensen, VN
Haraldsen, EK
Anderson, KB
Lonning, PE
Erikstein, B
Karesen, R
Gabrielsen, OS
Borresen-Dale, AL
Citation: Vn. Kristensen et al., CYP17 and breast cancer risk: The polymorphism in the 5 ' flanking area ofthe gene does not influence binding to Sp-1, CANCER RES, 59(12), 1999, pp. 2825-2828
Authors:
Launonen, V
Laake, K
Huusko, P
Niederacher, D
Beckmann, MW
Barkardottir, RB
Geirsdottir, EK
Gudmundsson, J
Rio, P
Bignon, YJ
Seitz, S
Scherneck, S
Bieche, I
Champeme, MH
Birnbaum, D
White, G
Varley, J
Sztan, M
Olah, E
Osorio, A
Benitez, J
Spurr, N
Velikonja, N
Peterlin, B
Borg, A
Cleton-Jansen, AM
Devilee, P
Bloigu, R
Lidereau, R
Borresen-Dale, AL
Winqvist, R
Citation: V. Launonen et al., European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables, BR J CANC, 80(5-6), 1999, pp. 879-882
Authors:
Clausen, OPF
Lothe, RA
Borresen-Dale, AL
De Angelis, P
Chen, Y
Rognum, TO
Meling, GI
Citation: Opf. Clausen et al., Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas, DIAGN MOL P, 7(4), 1998, pp. 215-223
Authors:
Devilee, P
Barkardottir, RB
Bevilacqua, G
Bignon, YJ
Bishop, T
Borg, A
Borresen-Dale, AL
Chang-Claude, J
Easton, D
Eyfjord, J
Feunteun, J
Goldgar, D
Haites, N
Holm, N
Kruse, T
Larsson, C
Lenoir, G
Lidereau, R
Nevanlinna, H
Ponder, B
Scherneck, S
Schmitt, F
Sobol, H
Solomon, E
Spurr, N
Steel, M
Stratton, M
Varley, J
Vasen, H
Vassilaros, S
Wagner, T
Willems, P
Winqvist, R
Citation: P. Devilee et al., Genetics and epidemiology of hereditary breast cancer, BIOM HLTH R, 24, 1998, pp. 339-346